• Lifecore Biomedical unit Lifecore Biomedical, LLC amended its contract manufacturing agreement with Alcon, effective Nov. 1, 2026.
• Term extended to Dec. 31, 2034 from Dec. 31, 2031, with automatic 24-month renewals unless either party gives notice.
• Amendment sets Alcon minimum purchase commitments through 2034, alongside Lifecore supply obligations.
• Lifecore agreed to restrict new deals to develop or manufacture certain products that directly compete with specified Alcon products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001005286-26-000036), on September 29, 2026, and is solely responsible for the information contained therein.